Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

METHOD - Phase I/II Study of Intramyocardial Injection of Bone Marrow Derived Mononuclear Cells in Chronic Ischemic Disease

NCT01666132 is registered in ClinicalTrials.gov with Cardiocentro Ticino as lead sponsor.

NCT NCT01666132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01666132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
METHOD - Phase I/II Study of Intramyocardial Injection of Bone Marrow Derived Mononuclear Cells in Chronic Ischemic Disease
Lead sponsor
Cardiocentro Ticino
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2011
Completion date
April 30, 2015
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic ischemic heart disease